Winners / 2025

CellBio™ a2000 for Cancer Screening

By: General Biologicals Corporation
Silver

Master Category:

Award Category: Health, Medical & Biotech

Award Sub-Category: Cancer Diagnostics and Treatment Technologies

CellBio a2000 technology is designed to ease out the cancer screening and monitoring by isolating and recognizing the circulating tumor cells in the blood. The open platform system not only provide new ways of diagnosis but also aid in developing precision medicine to reduce the risk of treatment.

Explore more Health & Wellness

Put your innovation in the spotlight.

For four decades, the Edison Awards have recognized innovative products, services, and technologies that create meaningful value and impact. Explore the categories, find the right fit, and enter your new innovation for recognition.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report